Sebhat Erqou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sebhat Erqou has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Wen-Chih Wu
14 shared publicationsJames L. Rudolph
11 shared publicationsGerald S. Bloomfield
10 shared publications- Wen-Chih Wu
Providence VA Medical Center
9 shared publications Lan Jiang
Department of Medicine, Providence VA Medical Center, Providence, RI; Center of Innovation in Long-Term Services and Supports (LTSS-COIN), Providence VA Medical Center, Providence, RI
7 shared publicationsChristopher T. Longenecker
Univ Washington, Global Hlth Inst, Seattle, WA USA
6 shared publications
Latest Publications
- Open Access
- 18 July 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 30
Developing machine learning models to improve cardiovascular risk prediction for people living with HIV
- 18 July 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 30
Open AccessDeveloping machine learning models to improve cardiovascular risk prediction for people living with HIV
- 16 June 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (24) , 1903-1914
Multidimensional Social Adversity and Mortality in People With HIV Infection and Heart Failure: Insights From NYC Health + Hospitals HIV–Heart Failure Cohort
BACKGROUND: Heart failure is an increasingly common comorbidity among people with HIV infection, complicating care and heightening the vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. METHODS: We analyzed data on people with HIV infection and heart failure from the NYC 4H (NYC Health + Hospitals HIV–Heart Failure) cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into 5 domains: economic hardship, health care access barriers, neighborhood or built environment instability, social support challenge, and psychobehavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality and logistic regression to estimate odds ratios of 6-month rehospitalization risk. RESULTS: Among 1044 participants (62.9% male; mean age, 61.6 years), 601 (58%) reported at least 1 SA: economic hardship (n=130), limited health care access (n=155), unstable housing (n=129), social support challenge (n=179), or psychobehavioral instability (n=438). Over a mean follow-up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR, 4.32 [95% CI, 3.03–6.14]), cardiovascular mortality (HR, 4.05 [95% CI, 2.17–6.83]), and infection-related mortality (HR, 2.37 [95% CI, 1.23–4.56]). Social support challenge (HR, 2.19 [95% CI, 1.35–3.55]) and psychobehavioral instability (HR, 1.96 [95% CI, 1.24–3.11]) were associated with higher cardiovascular mortality. Economic hardship (HR, 2.40 [95% CI, 1.22–4.70]) and social support challenge (HR, 3.09 [95% CI, 1.75–5.48]) were associated with higher infection-related mortality. Compared with patients without SA, those with environmental instability, psychobehavioral instability, or social support challenges had a 73% (adjusted odds ratio, 1.73 [95% CI, 1.15–2.06]), 75% (adjusted odds ratio, 1.75 [95% CI, 1.31–2.35]), and 44% (adjusted odds ratio, 1.44 [95% CI, 1.00-2.06]) higher risk of rehospitalization within 6 months, respectively. CONCLUSIONS: SA was significantly associated with mortality and rehospitalization among people with HIV infection and heart failure, with domain-specific pathways influencing specific outcomes. Multidimensional assessment of SA may offer a framework for domain-specific risk stratification in people with HIV infection and heart failure.
- 16 June 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (24) , 1903-1914
Multidimensional Social Adversity and Mortality in People With HIV Infection and Heart Failure: Insights From NYC Health + Hospitals HIV–Heart Failure Cohort
BACKGROUND: Heart failure is an increasingly common comorbidity among people with HIV infection, complicating care and heightening the vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. METHODS: We analyzed data on people with HIV infection and heart failure from the NYC 4H (NYC Health + Hospitals HIV–Heart Failure) cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into 5 domains: economic hardship, health care access barriers, neighborhood or built environment instability, social support challenge, and psychobehavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality and logistic regression to estimate odds ratios of 6-month rehospitalization risk. RESULTS: Among 1044 participants (62.9% male; mean age, 61.6 years), 601 (58%) reported at least 1 SA: economic hardship (n=130), limited health care access (n=155), unstable housing (n=129), social support challenge (n=179), or psychobehavioral instability (n=438). Over a mean follow-up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR, 4.32 [95% CI, 3.03–6.14]), cardiovascular mortality (HR, 4.05 [95% CI, 2.17–6.83]), and infection-related mortality (HR, 2.37 [95% CI, 1.23–4.56]). Social support challenge (HR, 2.19 [95% CI, 1.35–3.55]) and psychobehavioral instability (HR, 1.96 [95% CI, 1.24–3.11]) were associated with higher cardiovascular mortality. Economic hardship (HR, 2.40 [95% CI, 1.22–4.70]) and social support challenge (HR, 3.09 [95% CI, 1.75–5.48]) were associated with higher infection-related mortality. Compared with patients without SA, those with environmental instability, psychobehavioral instability, or social support challenges had a 73% (adjusted odds ratio, 1.73 [95% CI, 1.15–2.06]), 75% (adjusted odds ratio, 1.75 [95% CI, 1.31–2.35]), and 44% (adjusted odds ratio, 1.44 [95% CI, 1.00-2.06]) higher risk of rehospitalization within 6 months, respectively. CONCLUSIONS: SA was significantly associated with mortality and rehospitalization among people with HIV infection and heart failure, with domain-specific pathways influencing specific outcomes. Multidimensional assessment of SA may offer a framework for domain-specific risk stratification in people with HIV infection and heart failure.
- 23 March 2026
- Published by Wolters Kluwer Health in AIDS
- Vol. 40 (8) , 1097-1102
Estimating the degree of cardiovascular disease risk under-prediction in people with HIV by existing risk models: an updated meta-analysis
Background: The application of cardiovascular disease (CVD) risk models in people with HIV (PWH) may be limited due to concerns that the models tend to underestimate risk in this population. We conducted an updated meta-analysis to assess the degree of CVD risk under prediction in PWH by existing CVD risk models. Methods: We searched electronic databases and the reference lists of relevant articles. Data were abstracted using standardized forms. Calibration data included observed: expected ratios, which were graphically summarized. Weighted-regression models were fitted to estimate the relationship between observed and expected event rates across studies. Discrimination data included C -statistics which were pooled using random-effects model meta-analysis. Results: Sixteen publications reporting data on 97 945 PWH (mean age, 41 years; 75% male) were included. The risk scores tended to underpredict CVD risk in PWH, especially for individuals with lower expected risk. For PWH with expected 10-year CVD risk of 3%, the risk scores can underestimate risk by 71% on average. By contrast, for PWH with 6% and 9% expected 10-year CVD risk, the underestimation is by ~23% and ~7%, respectively. The risk scores had moderate performance in discrimination (pooled C -statistic values ranged from 0.71 to 0.82). There was substantial heterogeneity across studies and risk models. The 10-year models of the American Joint Societies Pooled Cohort Equation (PCE-10) and the Framingham Risk Score (FRS-10) had better calibration. Conclusions: Extant risk scores underpredict CVD risk in PWH, especially for individuals with lower expected risk, suggesting a need for implementation of HIV-specific calibration factors in this population. PCE-10 and FRS-10 showed better calibration.
- 23 March 2026
- Published by Wolters Kluwer Health in AIDS
- Vol. 40 (8) , 1097-1102
Estimating the degree of cardiovascular disease risk under-prediction in people with HIV by existing risk models: an updated meta-analysis
Background: The application of cardiovascular disease (CVD) risk models in people with HIV (PWH) may be limited due to concerns that the models tend to underestimate risk in this population. We conducted an updated meta-analysis to assess the degree of CVD risk under prediction in PWH by existing CVD risk models. Methods: We searched electronic databases and the reference lists of relevant articles. Data were abstracted using standardized forms. Calibration data included observed: expected ratios, which were graphically summarized. Weighted-regression models were fitted to estimate the relationship between observed and expected event rates across studies. Discrimination data included C -statistics which were pooled using random-effects model meta-analysis. Results: Sixteen publications reporting data on 97 945 PWH (mean age, 41 years; 75% male) were included. The risk scores tended to underpredict CVD risk in PWH, especially for individuals with lower expected risk. For PWH with expected 10-year CVD risk of 3%, the risk scores can underestimate risk by 71% on average. By contrast, for PWH with 6% and 9% expected 10-year CVD risk, the underestimation is by ~23% and ~7%, respectively. The risk scores had moderate performance in discrimination (pooled C -statistic values ranged from 0.71 to 0.82). There was substantial heterogeneity across studies and risk models. The 10-year models of the American Joint Societies Pooled Cohort Equation (PCE-10) and the Framingham Risk Score (FRS-10) had better calibration. Conclusions: Extant risk scores underpredict CVD risk in PWH, especially for individuals with lower expected risk, suggesting a need for implementation of HIV-specific calibration factors in this population. PCE-10 and FRS-10 showed better calibration.
- Open Access
- 5 March 2026
- Published by Elsevier in American Heart Journal
- Vol. 297, 107399
Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV
- 5 March 2026
- Published by Elsevier in American Heart Journal
- Vol. 297, 107399
Open AccessSystemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV
- Open Access
Multi-dimensional Social Adversity and Mortality Outcome in People Living With HIV and Heart Failure: Insights from NYC Health + Hospitals HIV-Heart Failure cohort
Background: Heart failure (HF) is an increasingly common comorbidity among people living with HIV (PLHIV), complicating care and heightening vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. Methods: We analyzed data on PLHIV with HF from the NYC Health + Hospitals HIV-Heart Failure cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into five domains: (1) economic hardship, (2) healthcare access barriers, (3) neighborhood/built environment instability, (4) social support challenge, and (5) Psycho-behavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality; and logistic regression to estimate odds ratios (ORs) of 6-month rehospitalization risk. Results: Among participants 1044 (62.9% males, mean age: 61.6 years), 601 (58%) reported at least 1social adversities: economic hardship (n=130), limited healthcare access (n=155), unstable housing (n=129), social support challenge (n=179), or psycho-behavioral instability (n=438). Over a mean follow up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR 4.32; 95% confidence interval [CI] 3.03–6.14), CV mortality (HR 4.05; 95% CI 2.17–6.83), and infection-related mortality (HR 2.37; 95% CI 1.23–4.56). Social support challenge (HR 2.19; 95% CI 1.35–3.55) and psycho-behavioral instability (HR 1.96; 95% CI 1.24–3.11) were associated with higher CV mortality; economic hardship (HR 2.40; 95% CI 1.22–4.70) and social support challenge (HR 3.09; 95% CI 1.75–5.48) were associated with higher infection-related mortality. Compared with patients without SA, those with an environment instability, psycho-behavioral instability, or social support challenges had a 73% (aOR 1.73; 95% CI, 1.15–2.06), 75% (aOR 1.75; 95% CI, 1.31–2.35), and 44% (aOR 1.44; 95% CI, 1.00-2.06) higher risk of rehospitalization within 6 months, respectively. Conclusion: SA was significantly associated with mortality and rehospitalization among PLHIV with HF, with domain-specific pathways influencing specific outcomes. A multidimensional assessment of social vulnerability may be useful to risk-stratify HF mortality risk in PLHIV.
Open AccessMulti-dimensional Social Adversity and Mortality Outcome in People Living With HIV and Heart Failure: Insights from NYC Health + Hospitals HIV-Heart Failure cohort
Background: Heart failure (HF) is an increasingly common comorbidity among people living with HIV (PLHIV), complicating care and heightening vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. Methods: We analyzed data on PLHIV with HF from the NYC Health + Hospitals HIV-Heart Failure cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into five domains: (1) economic hardship, (2) healthcare access barriers, (3) neighborhood/built environment instability, (4) social support challenge, and (5) Psycho-behavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality; and logistic regression to estimate odds ratios (ORs) of 6-month rehospitalization risk. Results: Among participants 1044 (62.9% males, mean age: 61.6 years), 601 (58%) reported at least 1social adversities: economic hardship (n=130), limited healthcare access (n=155), unstable housing (n=129), social support challenge (n=179), or psycho-behavioral instability (n=438). Over a mean follow up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR 4.32; 95% confidence interval [CI] 3.03–6.14), CV mortality (HR 4.05; 95% CI 2.17–6.83), and infection-related mortality (HR 2.37; 95% CI 1.23–4.56). Social support challenge (HR 2.19; 95% CI 1.35–3.55) and psycho-behavioral instability (HR 1.96; 95% CI 1.24–3.11) were associated with higher CV mortality; economic hardship (HR 2.40; 95% CI 1.22–4.70) and social support challenge (HR 3.09; 95% CI 1.75–5.48) were associated with higher infection-related mortality. Compared with patients without SA, those with an environment instability, psycho-behavioral instability, or social support challenges had a 73% (aOR 1.73; 95% CI, 1.15–2.06), 75% (aOR 1.75; 95% CI, 1.31–2.35), and 44% (aOR 1.44; 95% CI, 1.00-2.06) higher risk of rehospitalization within 6 months, respectively. Conclusion: SA was significantly associated with mortality and rehospitalization among PLHIV with HF, with domain-specific pathways influencing specific outcomes. A multidimensional assessment of social vulnerability may be useful to risk-stratify HF mortality risk in PLHIV.
- Open Access
- 17 September 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (10)
Re-evaluating Fasting Guidelines for Invasive Cardiac Procedures: A Systematic Review and Meta-analysis of Randomized Clinical Trials
- 17 September 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (10)
Open AccessRe-evaluating Fasting Guidelines for Invasive Cardiac Procedures: A Systematic Review and Meta-analysis of Randomized Clinical Trials
- Open Access
- 25 June 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (6) , 101807
Gestational Diabetes Mellitus and Heart Failure
- 25 June 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (6) , 101807
Open AccessGestational Diabetes Mellitus and Heart Failure
- Open Access
- 17 December 2024
- Published by Elsevier in JACC: Advances
- Vol. 4 (1) , 101462
Cardiovascular Risk Prediction Scores in Type 1 Diabetes
- 17 December 2024
- Published by Elsevier in JACC: Advances
- Vol. 4 (1) , 101462
Open AccessCardiovascular Risk Prediction Scores in Type 1 Diabetes
- 29 August 2024
- Published by Elsevier in American Heart Journal
- Vol. 278, 48-60
Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension
- 29 August 2024
- Published by Elsevier in American Heart Journal
- Vol. 278, 48-60
Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension
- Open Access
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (5) , e2411159
Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV
The widespread use of effective antiretroviral therapies (ARTs) has led to increased survivorship among people living with HIV. Therefore, people living with HIV are experiencing an increased prevalence of age-related disease, such as cardiovascular disease (CVD).1,2 The increase in CVD in this population has been attributed to multiple factors, including increasing age, the increase in burden of traditional CVD factors and psychosocial risk factors, the long-term metabolic effects of ART, and the low-grade immune activation of chronic HIV.1,3-8
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (5) , e2411159
Open AccessClinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV
The widespread use of effective antiretroviral therapies (ARTs) has led to increased survivorship among people living with HIV. Therefore, people living with HIV are experiencing an increased prevalence of age-related disease, such as cardiovascular disease (CVD).1,2 The increase in CVD in this population has been attributed to multiple factors, including increasing age, the increase in burden of traditional CVD factors and psychosocial risk factors, the long-term metabolic effects of ART, and the low-grade immune activation of chronic HIV.1,3-8